日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis

人乳头瘤病毒16型基因组内的遗传变异与口咽癌的预后相关。

期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2022.03.005
Lang Kuhs, K A; Faden, D L; Chen, L; Smith, D K; Pinheiro, M; Wood, C B; Davis, S; Yeager, M; Boland, J F; Cullen, M; Steinberg, M; Bass, S; Wang, X; Liu, P; Mehrad, M; Tucker, T; Lewis, J S; Ferris, R L; Mirabello, L
微生物学
肿瘤
口腔癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma

头颈部鳞状细胞癌的肿瘤免疫学和免疫疗法

期刊:
影响因子:
doi:10.1177/0022034518759464
Moskovitz, J M; Ferris, R L
肿瘤
肿瘤免疫
Immunology/Inflammation
细胞生物学
免疫/内分泌
发表日期：2018
文献求助 收藏

Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma

实性淋巴结作为人乳头瘤病毒相关口咽鳞状细胞癌风险分层的影像学生物标志物

期刊:American Journal of Neuroradiology
影响因子:3.7
doi:10.3174/ajnr.A5177
Rath, T J; Narayanan, S; Hughes, M A; Ferris, R L; Chiosea, S I; Branstetter, B F 4th
肿瘤
肿瘤免疫
微生物学
Human
细胞生物学
发表日期：2017
文献求助 收藏

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer

一项针对局部晚期头颈癌患者的II期随机试验，比较了放射治疗、西妥昔单抗和培美曲塞联合或不联合贝伐珠单抗的疗效。

期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdw204
Argiris, A; Bauman, J E; Ohr, J; Gooding, W E; Heron, D E; Duvvuri, U; Kubicek, G J; Posluszny, D M; Vassilakopoulou, M; Kim, S; Grandis, J R; Johnson, J T; Gibson, M K; Clump, D A; Flaherty, J T; Chiosea, S I; Branstetter, B; Ferris, R L
肿瘤
肿瘤免疫
头颈癌
发表日期：2016
文献求助 收藏

Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.

对高危头颈癌切除患者进行术后放疗联合顺铂加帕尼单抗治疗的 II 期试验

期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdw428
Ferris R L, Geiger J L, Trivedi S, Schmitt N C, Heron D E, Johnson J T, Kim S, Duvvuri U, Clump D A, Bauman J E, Ohr J P, Gooding W E, Argiris A
肿瘤
头颈癌
肿瘤免疫
发表日期：2016
文献求助 收藏

Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation

经口机器人根治性手术与根治性放化疗治疗口咽鳞状细胞癌患者的肿瘤学结果和患者报告的生活质量

期刊:Oral Oncology
影响因子:3.9
doi:10.1016/j.oraloncology.2016.08.004
Ling, D C; Chapman, B V; Kim, J; Choby, G W; Kabolizadeh, P; Clump, D A; Ferris, R L; Kim, S; Beriwal, S; Heron, D E; Duvvuri, U
细胞生物学
肿瘤
肿瘤免疫
发表日期：2016
文献求助 收藏

Immune biomarkers of anti-EGFR monoclonal antibody therapy

抗EGFR单克隆抗体疗法的免疫生物标志物

期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdu156
Trivedi, S; Concha-Benavente, F; Srivastava, R M; Jie, H B; Gibson, S P; Schmitt, N C; Ferris, R L
单克隆抗体
EGFR
EGF
免疫/内分泌
发表日期：2015
文献求助 收藏

Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer

PET/CT监测在头颈部鳞状细胞癌中的阴性预测值

期刊:American Journal of Neuroradiology
影响因子:3.7
doi:10.3174/ajnr.A3494
McDermott, M; Hughes, M; Rath, T; Johnson, J T; Heron, D E; Kubicek, G J; Kim, S W; Ferris, R L; Duvvuri, U; Ohr, J P; Branstetter, B F
细胞生物学
肿瘤
肿瘤免疫
发表日期：2013
文献求助 收藏

Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer

培美曲塞联合西妥昔单抗及同步放疗治疗头颈癌患者的I期临床试验

期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdr002
Argiris, A; Karamouzis, M V; Smith, R; Kotsakis, A; Gibson, M K; Lai, S Y; Kim, S; Branstetter, B F; Shuai, Y; Romkes, M; Wang, L; Grandis, J R; Ferris, R L; Johnson, J T; Heron, D E
肿瘤
肿瘤免疫
头颈癌
发表日期：2011
文献求助 收藏

Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy

采用RECIST标准，对接受放化疗的局部晚期头颈癌患者进行PET-CT联合扫描与单独CT扫描的疗效评估

期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdq226
Passero, V A; Branstetter, B F; Shuai, Y; Heron, D E; Gibson, M K; Lai, S Y; Kim, S W; Grandis, J R; Ferris, R L; Johnson, J T; Argiris, A
肿瘤
肿瘤免疫
头颈癌
发表日期：2010
文献求助 收藏